Financial conflicts of interest in economic analyses in oncology

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 5, 2011, Pages 524-528

  Jang, Sekwon ^a   Chae, Young Kwang ^b   Majhail, Navneet S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

conflict of interest; economic analysis; oncology

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; ECONOMIC EVALUATION; FINANCIAL MANAGEMENT; MEDICAL SOCIETY;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; HUMANS; MEDICAL ONCOLOGY;

EID: 80053373366     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181f4799b     Document Type: Article

References (24)

1. Institute of Medicine. Conflict of interest in medical research, education, and practice. Available from URL: http://www.iom. edu/CMS/3740/47464/65721.aspx [Accessed December 23, 2009].
2. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993;329:573-576. (Pubitemid 23232630)
3. Korn D. Conflicts of interest in biomedical research. JAMA. 2000;284:2234-2237.
4. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454-465. (Pubitemid 36119966)
5. Jrgensen AW, Hilden J, Gtzsche PC. Cochrane reviews compared with industry supported meta-analyses and other metaanalyses of the same drugs: systematic review. BMJ. 2006; 333:782.
6. Riechelmann RP, Wang L, OCarroll A, et al. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol. 2007;25:4642-4647. (Pubitemid 350035325)
7. Johnston KL, Go RS. Financial conflicts of interest among ASCO annual meeting abstract authors, speakers, and planners. J Natl Cancer Inst. 2007;99:1415-1416. (Pubitemid 351767181)
8. Hampson LA, Joffe S, Fowler R, et al. Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol. 2007;25:3609-3614. (Pubitemid 47372598)
9. Clement FM, Harris A, Li JJ, et al. Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada. JAMA. 2009; 302:1437-1443.
10. American College of Physicians. Information on costeffectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med. 2008;148: 956-961.
11. Friedberg M, Saffran B, Stinson TJ, et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999;282:1453-1457. (Pubitemid 29493799)
12. Hartmann M, Knoth H, Schulz D, et al. Industrysponsored economic studies in oncology versus studies sponsored by nonprofit organizations. Br J Cancer. 2003;89:1405-1408. (Pubitemid 37386591)
13. American Society of Hematology. Annual meeting abstracts. Available from URL http://bloodjournal.hematologylibrary.org/misc/ASH-Meeting-Abstracts-Info. dtl [Accessed in March 2009].
14. American Society of Clinical Oncology. Annual meeting abstracts. Available from URL http://jco.ascopubs.org/search.dtl [Accessed in Mach 2009].
15. Okike K, Kocher MS, Wei EX, et al. Accuracy of conflictof-interest disclosures reported by physicians. N Engl J Med. 2009;361:1466-1474.
16. Jagsi R, Sheets N, Jankovic A, et al. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer. 2009;115:2783-2791.
17. Okike K, Kocher MS, Mehlman CT, et al. Conflict of interest in orthopaedic research. An association between findings and funding in scientific presentations. J bone Joint Surg Am. 2007;89:608-613. (Pubitemid 46365361)
18. Brown SD, Daly JC, Kalish LA, et al. Financial disclosures of scientific papers presented at the 2003 RSNA annual meeting: association with reporting of non-Food and Drug Administrationapproved uses of industry products. Radiology. 2006;239: 849-855. (Pubitemid 43830622)
19. Holloway RG, Mooney CJ, Getchius TSD, et al. Invited article: conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology. 2008;71:57-63.
20. Lurie P, Almeida CM, Stine N, et al. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration drug advisory committee meetings. JAMA. 2006;295:1921-1928.
21. Bell CM, Urbach DR, Ray JG, et al. Bias in published cost effectiveness studies: systematic review. BMJ. 2006;332:699-703.
22. Fugh-Berman A, Dodgson SJ. Ethical considerations of publication planning in the pharmaceutical industry. Open Med. 2008; 2:e33-e36.
23. Jang S, Chae YK, Haddad T, et al. Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review. Breast Cancer Res Treat. 2010 [Epub ahead of print].
24. Krimsky S. Conflict of interest and cost-effectiveness analysis. JAMA. 1999;282:1474-1475. (Pubitemid 29493803)